HW211026 Ointment

· Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HW211026 Ointment, covering 2026-01-06 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis. [Phase 1]